Abstract:Pancreatic ductal adenocarcinoma (PDAC) is a silent killer, often diagnosed late. However, it is also dishearteningly resistant to nearly all forms of treatment. New therapies are urgently needed, and with the advent of organoid culture for pancreatic cancer, an increasing number of innovative approaches are being tested. Organoids can be derived within a short enough time window to allow testing of several anticancer agents, which opens up the possibility for functional precision medicine for pancreatic cancer. At the same time, organoid model systems are being refined to better mimic the cancer, for example, by incorporation of components of the tumor microenvironment. We review some of the latest developments in pancreatic cancer organoid research and in novel treatment design. We also summarize our own current experiences with pancreatic cancer organoid drug sensitivity and resistance testing (DSRT) in 14 organoids from 11 PDAC patients. Our data show that it may be necessary to include a cell death read-out in ex vivo DSRT assays, as metabolic viability quantitation does not capture actual organoid killing. We also successfully adapted the organoid platform for drug combination synergy discovery. Lastly, live organoid culture 3D confocal microscopy can help identify individual surviving tumor cells escaping cell death even during harsh combination treatments. Taken together, the organoid technology allows the development of novel precision medicine approaches for PDAC, which paves the way for clinical trials and much needed new treatment options for pancreatic cancer patients.

Pancreas 3D Organoids: Current and Future Aspects as a Research Platform for Personalized Medicine in Pancreatic Cancer

Pancreatic Cancer Organoids: An Emerging Platform for Precision Medicine?

A Prospective Advanced Model for Pancreatic Cancer Research

A Pancreas Tumor Derived Organoid Study: from Drug Screen to Precision Medicine

Organoids Models of Pancreatic Duct Adenocarcinoma

Research Status and Application Prospect of Personalizing Pancreatic Cancer Organoids in The Era of Precision Medicine

Organoid Models of Human and Mouse Ductal Pancreatic Cancer

Advances and Applications of Cancer Organoids in Drug Screening and Personalized Medicine

Advancements in Preclinical Models of Pancreatic Cancer

Pancreatic Cancer Organoids in the Field of Precision Medicine: A Review of Literature and Experience on Drug Sensitivity Testing with Multiple Readouts and Synergy Scoring

The application of pancreatic cancer organoids for novel drug discovery

Ultrasound-guided fine-needle aspiration/biopsy-based pancreatic organoids establishment: an alternative model for basic and preclinical research

A 3D Bio-Printed-Based Model for Pancreatic Ductal Adenocarcinoma

Patient-Derived Xenograft Models of Pancreatic Cancer: Overview and Comparison with Other Types of Models

Bioengineering Approaches for the Pancreatic Tumor Organoids Research and Application

Organoid model: A new hope for pancreatic cancer treatment?

Pancreatic Organoids: A Frontier Method for Investigating Pancreatic-Related Diseases

Organoid Technology and Clinical Applications in Digestive System Cancer

Personalized Medicine in Pancreatic Cancer: The Promise of Biomarkers and Molecular Targeting with Dr. Michael J. Pishvaian

Deconstructing Pancreatic Cancer Using Next Generation-Omic Technologies–From Discovery to Knowledge-Guided Platforms for Better Patient Management

Hacking Pancreatic Cancer: Present and Future of Personalized Medicine